look news india
New Delhi: Calendar year 2024 has proved to be an extraordinary year for India’s primary market. Over 317 IPOs have raised Rs 1.8 lakh crore so far in 2024, the highest ever. This figure collected in the calendar year 2021 is Rs. 1.3 lakh crore has also been crossed and in the calendar year 2023 Rs. Much more than 576 billion. Investors are happy with the primary market.
The contribution of IPOs to the Indian market capitalization has increased significantly. It has increased from 1.4% in 2023 to 2.9% in 2024. However, despite this jump, it still lags behind 2017 (3.7%) and 2021 (3.4%).
However, the contribution of SME IPOs remained low in the year 2024. This represents 5.3% of total IPO activity, down from 8.6% in 2023. Despite the low share, the total capital raised by SMEs in 2024 is expected to be Rs. 92 billion, which will increase to Rs. 92 billion in 2023. 49 billion was twice the total capital. SMEs are still an important factor in diversifying the IPO landscape.
Hyundai Motor has created history with the largest IPO in India. It earned Rs. 278.6 billion, surpassing the previous record (Rs 205.6 billion) set by LIC in May 2022. The year also saw India’s largest follow-on public offering (FPO), with Vodafone-Idea raising $180 billion in April 2024. This surpassed the previous records of Yes Bank (Rs 150 billion) in July 2020 and ONGC (Rs 106.9 billion) in March 2004.
Healthcare and Pharma. The sector has earned Rs. Gathered. 14,811 crores were raised
India’s healthcare and pharmaceutical sector to raise Rs.100 crore through IPO in 2024 Rs 14,811 crore has been collected. This is the highest amount raised since 2019 due to strong domestic demand amid growing global opportunities.
According to the data, PSI Life Sciences (Rs 3,043 crore), IKS Health (Rs 2,498 crore), Cegility India (Rs 2,107 crore) contributed significantly in raising the record amount. Although there have been fewer IPOs in this sector this year compared to last year, there has been a significant jump in the average issue size. Last year there were issues of 21 companies and this year 13 companies have entered the market. The pharmaceutical industry in India has become one of the top sectors attracting investment.
